Humira is an anti-TNF monoclonal antibody that currently treats Crohn's disease, rheumatoid arthritis, ulcerative colitis, hidradenitis suppurativa, psoriasis, psoriatic arthritis, juvenile idiopathic arthritis, ankylosing spondylitis and uveitis.
Type of Molecule
Biologic
Target
TNF
Region
US, EU, Japan
| Potential Indication | Product Type | Phase (1, 2, 3, Submitted, Approved) |
|---|---|---|
| Hidradenitis Suppurativa (HS) (US, EU) | New Indication | Phase Approved Approved |
| Uveitis (US, EU, JAPAN) | New Indication | Phase Approved Approved |